22 May 2020 - A drug maker in Bangladesh has become the first company to sell a generic version of remdesivir, the latest sign of how the push to ensure widespread access to COVID-19 medicines and vaccines has become an urgent issue in poor countries.
Following an emergency decree issued by the Bangladesh government, Beximco Pharmaceuticals is donating copies of the Gilead Sciences medicine to state-run hospitals free of charge, but will sell the intravenous treatment to private clinics.